← Back to news

Markets

The SpaceX IPO Is Coming. Cathie Wood’s Ark Venture and More Funds to Get in on the Action.

Y

HP Is Positioning Itself for the AI Gold Rush's Second Act

Y

Why Arm's New AI Chip Is a Game Changer. Time to Buy the Stock?

Y

Fifth Third (FITB) Expands App Capabilities, Truist Lowers PT

Y

BofA Names East West Bancorp (EWBC) a Top Pick, Morgan Stanley Raises PT

Y

Analysts Have Mixed Views on Glacier Bancorp (GBCI)

Y

Jefferies’ Investment-Banking Windfall Eroded by Credit Woes

Y

EchoStar Stock Just Broke Above Its 50-Day Moving Average on SpaceX IPO Hype. Does That Make SATS a Buy?

Y

Wintrust Financial (WTFC) Shares Growth Plans at RBC Conference

Y

Hovde Group Upgrades SouthState Bank (SSB) to Outperform

Y

DA Davidson Reiterates Buy Rating on Axos Financial (AX)

Y

Truist Cuts UMB Financial (UMBF) Price Target, Morgan Stanley Raises

Y

Pinnacle Financial (PNFP) Grows Jacksonville Team, Opens New Alabama Office

Y

Travel tech firm Navan sees strong 2027 revenue on demand from new customers

Y

Why TD Cowen Turned More Cautious on Macy’s (M) Despite a Fourth-Quarter Beat

Y

HELOC rates fall near 7% as home equity loan rates hold the line

Y

Why DA Davidson Thinks Target (TGT)’s Turnaround Case Deserves a Higher Valuation

Y

How Improving Sales Trends Changed Wall Street’s Tone on Chipotle (CMG)

Y

Why Piper Sandler Sees Dollar General (DG)’s 2026 Growth Setup as Less Straightforward Than It Looks

Y

How Dollar Tree (DLTR) Is Using Store Closures and Higher Price Points to Defend Margins

Y

Stock market today: Dow, S&P 500, Nasdaq rise on hopes of US-Iran talks, oil drops below $100

Y

Why BofA Sees Kohl’s (KSS) Facing a Tougher Road to a Real Turnaround

Y

Gas Crisis Dwarfs Oil Shock as LNG Supply Breaks

Y

How Rising Fuel Costs Drove Fresh Target Cuts on Frontier Group (ULCC)

Y

Why Higher Jet-Fuel Costs Are Clouding Delta (DAL)’s Near-Term Earnings Outlook

Y

How Fuel Inflation Forced a Reset in Wall Street’s View of American Airlines (AAL)

Y

Micron Broke Below Its 50-Day Moving Average. Should You Buy the Dip?

Y

Why Analysts Cut United Airlines (UAL) Targets Even as Demand Held Up

Y

Don't Buy PayPal's Stock Until These 3 Things Happen

Y

Google Stock Slides Toward Bear Market Territory. Time to Buy?

Y

Treasury Yields Fall as Markets Watch Developments in Iran

Y

Tesla (TSLA) Accelerates Its Autonomous Driving Roadmap By Vertically Integrating Its Semiconductor Production

Y

On Holding shakes up leadership team in response to rising pressure, says Jefferies

Y

Analysts Remain Bullish on RTX (RTX) Following Completion of Its $115 Million Redstone Missile Integration Plant Investment Expansion

Y

Is Palantir Stock a Long-Term Buy?

Y

Analysts Remain Mixed on Caterpillar (CAT) Amid Power-Generation Equipment Agreement with Atlas Energy

Y

Walmart (WMT) Emerging As Frontrunner Amid Accelerating AI Adoption Across Retail, According to Jefferies

Y

“We Don’t See the Defense Demand Waning at All,” Says Honeywell International (HON)’s Jim Currier

Y

New Mexico jury approves $375M in civil damages against Meta

Y

Teradyne (TER) to Facilitate Production of High-Volume Silicon Photonics and Co-Packaged Optics with Photon 100 Launch

Y

Analysts Bullish on Costco Wholesale (COST) Despite Increasing Concerns Regarding Membership Growth Trends and Valuation

Y

Analysts Mixed on Norfolk Southern (NSC) Amid Pricing and Competition Concerns

Y

Nextpower (NXT) to Deliver Another Robust Quarter Despite Solar Industry Headwinds, According to Jefferies

Y

Punitive Damages Award Worth $950 Million Overturned Against Johnson & Johnson (JNJ), $16M Talc Verdict Stands

Y

When will I get my tax refund? How to check your IRS status.

Y

Corning (GLW) to Showcase New AI-Driven Optical Communication Breakthroughs At the Optical Fiber Communication Conference 2026

Y

Analysts Remain Confident in Reviva Pharmaceuticals Holdings (RVPH) Amid 1-for-20 Reverse Stock Split

Y

Dollar Supported by Ongoing US-Iran War

Y

Strong Analyst Sentiment on TScan Therapeutics (TCRX) Amid Ongoing Momentum in Cell Therapy Space

Y

Analysts Remain Optimistic in Sagimet Biosciences (SGMT)’s Outlook Following Q4 and Full-Year 2025 Results

Y